We are live on ! Find out more
O

Ossiam Portfolio holdings

AUM $5.69B
1-Year Est. Return 30.95%
This Fund
S&P 500
This Quarter Est. Return
+8.43%
1 Year Est. Return
+30.95%
3 Year Est. Return
+104.81%
5 Year Est. Return
+127.55%
10 Year Est. Return
AUM
$1.31B
AUM Growth
-$122M
Cap. Flow
-$203M
Cap. Flow %
-15.51%
Top 10 Hldgs %
37.2%
Holding
529
New
58
Increased
189
Reduced
228
Closed
54

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$55.6M
2
MA icon
Mastercard
MA
+$42M
3
PG icon
Procter & Gamble
PG
+$37.7M
4
T icon
AT&T
T
+$36.5M
5
AMGN icon
Amgen
AMGN
+$28.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$71.9M
2
WFC icon
Wells Fargo
WFC
+$50.4M
3
LIN icon
Linde
LIN
+$39.2M
4
DIS icon
Walt Disney
DIS
+$39M
5
CVS icon
CVS Health
CVS
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 23.16%
2 Communication Services 14.07%
3 Healthcare 13.47%
4 Financials 12.21%
5 Consumer Staples 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIA
526
DELISTED
Viacom Inc. Class A
VIA
-1
Closed
SIVB
527
DELISTED
SVB Financial Group
SIVB
-241
Closed -$50K
MBT
528
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
-203,794
Closed -$1.65M
CELG
529
DELISTED
Celgene Corp
CELG
-724,407
Closed -$71.9M

Similar funds

Ossiam's Q4 2019 Portfolio in Review

As of Q4 2019, Ossiam held 529 positions worth $1.31B, down 8.5% from $1.43B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ossiam withdrew a net $203M in Q4 2019, closing 54 positions and reducing 228 holdings. Its most notable exit was Celgene Corp, an estimated $71.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Ossiam opened a new position in Alcon worth $14.8M.

  • Ossiam's largest Q4 2019 buy was Alcon: 260,957 shares worth $14.8M.
  • Ossiam added most to Johnson & Johnson in Q4 2019, an estimated $55.6M increase.
  • Ossiam's biggest Q4 2019 reduction was Linde, cutting an estimated $39.2M.
  • Ossiam fully exited Celgene Corp in Q4 2019, selling an estimated $71.9M.
  • Ossiam's ten largest holdings make up 37% of its $1.31B portfolio in Q4 2019.
  • Ossiam opened 58 new positions and closed 54 in Q4 2019.
  • Ossiam's portfolio value fell 8.5% quarter-over-quarter to $1.31B.

Based on Ossiam's 13F filing for Q4 2019, filed 14 Feb 2020.